233 related articles for article (PubMed ID: 34355492)
1. Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis.
Mestre L; Alonso G; Feliú A; Mecha M; Martín C; Villar LM; Guaza C
Aging Cell; 2021 Sep; 20(9):e13440. PubMed ID: 34355492
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
Leitzen E; Jin W; Herder V; Beineke A; Elmarabet SA; Baumgärtner W; Hansmann F
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823515
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.
Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Espejo C; Álvarez-Cermeño JC; Villar LM; Guaza C
Front Immunol; 2019; 10():1374. PubMed ID: 31258540
[TBL] [Abstract][Full Text] [Related]
4. The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System.
DePaula-Silva AB
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257819
[TBL] [Abstract][Full Text] [Related]
5. Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.
DiSano KD; Linzey MR; Royce DB; Pachner AR; Gilli F
J Neuroinflammation; 2019 May; 16(1):109. PubMed ID: 31118079
[TBL] [Abstract][Full Text] [Related]
6. IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease.
Bowen JL; Olson JK
Viral Immunol; 2013 Aug; 26(4):223-38. PubMed ID: 23829778
[TBL] [Abstract][Full Text] [Related]
7. Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.
Kim BS
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067536
[TBL] [Abstract][Full Text] [Related]
8. The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Gilli F; Li L; Pachner AR
J Neurovirol; 2016 Feb; 22(1):66-79. PubMed ID: 26260496
[TBL] [Abstract][Full Text] [Related]
9. Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.
Martinez NE; Sato F; Kawai E; Omura S; Takahashi S; Yoh K; Tsunoda I
Brain Behav Immun; 2015 Jan; 43():86-97. PubMed ID: 25046854
[TBL] [Abstract][Full Text] [Related]
10. Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis.
DiSano KD; Royce DB; Gilli F; Pachner AR
Front Immunol; 2019; 10():1821. PubMed ID: 31428102
[TBL] [Abstract][Full Text] [Related]
11. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.
Dal Canto MC; Melvold RW; Kim BS; Miller SD
Microsc Res Tech; 1995 Oct; 32(3):215-29. PubMed ID: 8527856
[TBL] [Abstract][Full Text] [Related]
12. Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.
Carrillo-Salinas FJ; Mestre L; Mecha M; Feliú A; Del Campo R; Villarrubia N; Espejo C; Montalbán X; Álvarez-Cermeño JC; Villar LM; Guaza C
Sci Rep; 2017 Mar; 7():44377. PubMed ID: 28290524
[TBL] [Abstract][Full Text] [Related]
13. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.
Duncan DS; Miller SD
PLoS One; 2011 Apr; 6(4):e18548. PubMed ID: 21494618
[TBL] [Abstract][Full Text] [Related]
14. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Kaneyama T; Tomiki H; Tsugane S; Inaba Y; Ichikawa M; Akiba H; Yagita H; Kim BS; Koh CS
Int Immunol; 2014 Jul; 26(7):369-81. PubMed ID: 24486565
[TBL] [Abstract][Full Text] [Related]
15. Antibody response is required for protection from Theiler's virus-induced encephalitis in C57BL/6 mice in the absence of CD8+ T cells.
Kang BS; Palma JP; Lyman MA; Dal Canto M; Kim BS
Virology; 2005 Sep; 340(1):84-94. PubMed ID: 16039687
[TBL] [Abstract][Full Text] [Related]
16. Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis.
Tsunoda I; Fujinami RS
J Neuroimmune Pharmacol; 2010 Sep; 5(3):355-69. PubMed ID: 19894121
[TBL] [Abstract][Full Text] [Related]
17. A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection.
McDole J; Suidan G; Boespflug E; Cheng J; Chen Y; Pirko I; Johnson A
Hum Immunol; 2008 Nov; 69(11):805-10. PubMed ID: 18817825
[TBL] [Abstract][Full Text] [Related]
18. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
[TBL] [Abstract][Full Text] [Related]
19. A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Wootla B; Denic A; Watzlawik JO; Warrington AE; Rodriguez M
J Neuroinflammation; 2015 Apr; 12():83. PubMed ID: 25924771
[TBL] [Abstract][Full Text] [Related]
20. Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Takizawa S; Kaneyama T; Tsugane S; Takeichi N; Yanagisawa S; Ichikawa M; Yagita H; Kim BS; Koh CS
J Neuroimmunol; 2014 Sep; 274(1-2):78-85. PubMed ID: 25027060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
